Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Acq. announced
Appointed director
Notes underwriting agrmnt
|
|
MedTech Acquisition Corp
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 08/23/2023 |
SC 13G
| Lombard International Assurance S.A. reports a 5.2% stake in TriSalus Life Sciences Inc. |
| 08/22/2023 |
SC 13G
| Stansky Michael P reports a 5.3% stake in TRISALUS LIFE SCIENCES, INC. |
| 08/21/2023 |
SC 13D
| MATLIN DAVID J reports a 8.2% stake in TriSalus Life Sciences, Inc. |
| 08/21/2023 |
SC 13G
| Dewey Christopher C reports a 5.6% stake in TRISALUS LIFE SCIENCES, INC. |
| 08/21/2023 |
SC 13D
| Wahlstrom Mats reports a 10.4% stake in TriSalus Life Sciences, Inc. |
| 08/21/2023 |
SC 13G
| MCGREVIN GENE R reports a 5.3% stake in TriSalus Life Sciences, Inc. |
| 08/21/2023 |
SC 13D
| Frankenius Equity AB reports a 24.1% stake in TriSalus Life Sciences, Inc. |
| 08/16/2023 |
8-K
| Director compensation was amended/approved, Acquisition/merger/asset purchase announced|
Docs:
|
"Second Amended and Restated Certificate of Incorporation of TriSalus Life Sciences, Inc",
"Amended and Restated Bylaws of TriSalus Life Sciences, Inc",
"Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of TriSalus Life Sciences, Inc",
"Specimen Common Stock Certificate",
"Specimen Warrant Certificate",
"Description of Common Stock",
"April 5, 2023",
"April 5, 2023",
"April 5, 2023",
"April 5, 2023" |
|
| 08/15/2023 |
4
| Szela Mary T (CEO and President) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 172,500 options to buy
@ $11.51, valued at
$2M
|
|
| 08/15/2023 |
3
| Szela Mary T (CEO and President) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| Stevens Jennifer (Chief Regulatory Officer) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12, valued at
$480k
|
|
| 08/14/2023 |
3
| Stevens Jennifer (Chief Regulatory Officer) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| Murphy Sean (CFO) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 62,500 options to buy
@ $12, valued at
$750k
|
|
| 08/14/2023 |
3
| Murphy Sean (CFO) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| Marshak Richard (Sr.VP, Corp. Dev. & Strategy) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12, valued at
$480k
|
|
| 08/14/2023 |
3
| Marshak Richard (Sr.VP, Corp. Dev. & Strategy) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| Katz Steven C (Chief Medical Officer) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 62,500 options to buy
@ $12, valued at
$750k
|
|
| 08/14/2023 |
3
| Katz Steven C (Chief Medical Officer) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| Cox Bryan F. (Chief Scientific & Manufact.) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12, valued at
$480k
|
|
| 08/14/2023 |
3
| Cox Bryan F. (Chief Scientific & Manufact.) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
3
| Alecxih James (President, Device Technology) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
3
| Frankenius Equity AB (10% Owner) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| Wahlstrom Mats (10% Owner) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
3
| Wahlstrom Mats (10% Owner) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| VON ESCHENBACH ANDREW C. (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
3
| VON ESCHENBACH ANDREW C. (Director) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| Singhal Anil K. (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
3
| Singhal Anil K. (Director) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| MATLIN DAVID J (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Acquired 931,904 shares
@ $0
Acquired 1,240,518 options to buy
@ $11.5, valued at
$14.3M
Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
Granted 100,000 preferred shares
@ $10, valued at
$1M
|
|
| 08/14/2023 |
4
| Martin George Kelly (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
3
| Martin George Kelly (Director) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 08/14/2023 |
4
| HICKS KERRY R (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
3
| HICKS KERRY R (Director) has filed a Form 3 on TriSalus Life Sciences, Inc. |
|
|
|